Translational pharmacokinetic (PK), pharmacodynamic (PD) modeling and simulation analysis of MetMAb

被引：1
|
作者：
Bender, B. [1 ]
Xiang, H. [2 ]
Reyes, A. E., II [2 ]
Damico, L. A. [2 ]
Merchant, M. [3 ]
Peterson, A. [4 ]
Forrest, W. [5 ]
Jumbe, N. L. [1 ]
机构：
[1] Genentech Inc, Clin PKIPD, San Francisco, CA USA
[2] Genentech Inc, Early Dev PKIPD, San Francisco, CA USA
[3] Genentech Inc, Translat BioOncol, San Francisco, CA USA
[4] Genentech Inc, Clin BioOncol, San Francisco, CA USA
[5] Genentech Inc, NonClin Biostat, San Francisco, CA USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(08)72473-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] POPULATION PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) MODELING OF TICARCILLIN-CLAVULANATE IN PEDIATRIC CF PATIENTS
    Zobell, J. T.
    Stockmann, C.
    Young, D. C.
    Cash, J.
    Sherwin, C.
    Spigarelli, M.
    Chatfield, B. A.
    Ampofo, K.
    PEDIATRIC PULMONOLOGY, 2011, : 311 - 312
  • [42] Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat
    Miyazaki, M
    Maekawa, C
    Iwanaga, K
    Morimoto, K
    Kakemi, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (11) : 1363 - 1369
  • [43] Semi-physiological pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for thrombocytopenia in rats
    Kobuchi, Shinji
    Ito, Yukako
    Hayakawa, Taro
    Nishimura, Asako
    Shibata, Nobuhito
    Takada, Kanji
    Sakaeda, Toshiyuki
    XENOBIOTICA, 2015, 45 (01) : 19 - 28
  • [44] Translational PK/PD Modeling of Therapeutic Antibodies
    Alifrangis, Lene
    DRUG METABOLISM REVIEWS, 2009, 41 : 10 - 10
  • [45] Translational PK-PD modeling in pain
    Yassen, Ashraf
    Passier, Paul
    Furuichi, Yasuhisa
    Dahan, Albert
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (03) : 401 - 418
  • [46] Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses to Support Olaparib Tablet Approval in Ovarian Cancer
    Xu, Hongmei
    Zhou, Diansong
    Li, Jianguo
    Berges, Alienor
    Bui, Khanh
    Milenkova, Tsveta
    Tomkinson, Helen
    Al-Huniti, Nidal
    Learoyd, Maria
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S36 - S36
  • [47] Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of serdemeten-induced QTc effects in a first-in-human study
    Huntjens, D. R.
    Van Beijsterveldt, L.
    Kraljevic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Establishment of a fexofenadine population pharmacokinetic (PK)-pharmacodynamic (PD) model and exploration of dosing regimens through simulation
    Jang, Ji-Hun
    Jeong, Seung-Hyun
    Lee, Yong-Bok
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (03) : 427 - 441
  • [49] Establishment of a fexofenadine population pharmacokinetic (PK)–pharmacodynamic (PD) model and exploration of dosing regimens through simulation
    Ji-Hun Jang
    Seung-Hyun Jeong
    Yong-Bok Lee
    Journal of Pharmaceutical Investigation, 2023, 53 : 427 - 441
  • [50] A4S: A user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulation
    Germani, Massimiliano
    Del Bene, Francesca
    Rocchetti, Maurizio
    Van Der Graaf, Piet H.
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 110 (02) : 203 - 214
12345